NASDAQ:XXII

22nd Century Group (XXII) Stock Price, News & Analysis

$1.73
-0.10 (-5.46%)
(As of 04/26/2024 ET)
Today's Range
$1.70
$1.97
50-Day Range
$1.48
$43.01
52-Week Range
$1.45
$180.91
Volume
780,171 shs
Average Volume
4.47 million shs
Market Capitalization
$6.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$100.00

22nd Century Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
5,680.3% Upside
$100.00 Price Target
Short Interest
Bearish
12.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.05mentions of 22nd Century Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.85 out of 5 stars

XXII stock logo

About 22nd Century Group Stock (NASDAQ:XXII)

22nd Century Group, Inc., a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands. The company was founded in 1998 and is headquartered in Mocksville, North Carolina.

XXII Stock Price History

XXII Stock News Headlines

Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
22nd Century Group Inc
Notable earnings before Thursday's open
XXII May 2024 2.000 put
XXII Jan 2026 0.500 put
XXII Mar 2024 0.500 put
XXII Jul 2024 1.000 call
MO Mar 2024 37.500 put
PM Mar 2024 91.000 put
Stocks open higher coming off of Thursday's Nvidia rally
MO Mar 2024 40.500 put
MO Mar 2024 31.000 call
MO Mar 2024 41.500 put
See More Headlines
Receive XXII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
4/27/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Cigarettes
Sub-Industry
Cannabis
Current Symbol
NASDAQ:XXII
Employees
64
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$100.00
High Stock Price Target
$120.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+5,680.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$-140,770,000.00
Net Margins
-167.13%
Pretax Margin
-169.66%

Debt

Sales & Book Value

Annual Sales
$32.20 million
Book Value
($3.09) per share

Miscellaneous

Free Float
3,469,000
Market Cap
$6.02 million
Optionable
Optionable
Beta
1.53
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


XXII Stock Analysis - Frequently Asked Questions

Should I buy or sell 22nd Century Group stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" XXII shares.
View XXII analyst ratings
or view top-rated stocks.

What is 22nd Century Group's stock price target for 2024?

4 equities research analysts have issued 1-year price objectives for 22nd Century Group's shares. Their XXII share price targets range from $80.00 to $120.00. On average, they predict the company's share price to reach $100.00 in the next twelve months. This suggests a possible upside of 5,680.3% from the stock's current price.
View analysts price targets for XXII
or view top-rated stocks among Wall Street analysts.

How have XXII shares performed in 2024?

22nd Century Group's stock was trading at $47.6672 at the beginning of 2024. Since then, XXII shares have decreased by 96.4% and is now trading at $1.73.
View the best growth stocks for 2024 here
.

Are investors shorting 22nd Century Group?

22nd Century Group saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 519,900 shares, an increase of 170.8% from the March 31st total of 192,000 shares. Based on an average daily trading volume, of 1,420,000 shares, the short-interest ratio is currently 0.4 days. Approximately 12.1% of the shares of the company are sold short.
View 22nd Century Group's Short Interest
.

When is 22nd Century Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our XXII earnings forecast
.

How were 22nd Century Group's earnings last quarter?

22nd Century Group, Inc. (NASDAQ:XXII) posted its earnings results on Thursday, November, 4th. The biotechnology company reported ($230.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($153.60) by $76.80. The biotechnology company had revenue of $7.81 million for the quarter, compared to the consensus estimate of $8 million. 22nd Century Group had a positive trailing twelve-month return on equity of 7.51% and a negative net margin of 167.13%.

What ETF holds 22nd Century Group's stock?

Amplify Alternative Harvest ETF holds 12,679 shares of XXII stock, representing 0.01% of its portfolio.

When did 22nd Century Group's stock split?

22nd Century Group shares reverse split on the morning of Tuesday, April 2nd 2024. The 1-16 reverse split was announced on Tuesday, April 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

What other stocks do shareholders of 22nd Century Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI).

How do I buy shares of 22nd Century Group?

Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XXII) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners